Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Isabel Breyer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, BK Virus, Polyomavirus Infections, Graft Survival. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
BK polyomavirus (BKPyV)‐DNAemia is a common complication in kidney transplant recipients (KTRs). The significance of achieving viral clearance at different time intervals is not well understood.
Methods
All adult KTRs transplanted between January 1, 2015 and December 31, 2017 who developed BKPyV‐DNAemia were included. Outcomes were analyzed based on persistent clearance of BKPyV‐DNAemia at 3‐month intervals up to 2 years after initial detection, and for recipients with persistent BKPyV‐DNAemia at last follow‐up. Uncensored graft failure, death‐censored graft failure (DCGF), and a composite outcome of DCGF or fall in estimated glomerular filtration rate (eGFR) by ≥50% from the time of initial BKPyV‐DNAemia were outcomes of interest.
Results
Of 224 KTRs with BKPyV‐DNAemia, 58 recipients (26%) achieved viral clearance by 3 months after initial detection, 105 (47%) by 6 months, 120 (54%) by 9 months, 141 (63%) by 12 months, 155 (69%) by 15 months, 167 (75%) by 18 months, 180 (80%) by 21 months, and 193 (86%) by 24 months. Nine recipients (4%) had persistent BKPyV‐DNAemia at last follow‐up. Compared to recipients who achieved viral clearance by 3 months, those who achieved clearance by 6 months (adjusted odds ratio [aOR]: 3.15; 95% confidence interval [CI]: 1.22–8.12; p = .02) and 9 months (aOR: 3.69; 95% CI: 1.02–13.43; p = .04) had significantly increased risk for uncensored graft failure. There was no significant association between time to viral clearance and DCGF or composite outcomes.
Conclusions
We found a trend of increased risk for uncensored graft failure among those who cleared BKPyV‐DNAemia more slowly. Aiming to clear viremia early, without risking rejection, may be beneficial for allograft function and patient morbidity and mortality. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
ORCID-Profile: Didier Mandelbrot, Sandesh Parajuli
Zitieren
APA
Breyer, I., Ptak, L., Stoy, D., Mandelbrot, D., & Parajuli, S. (2024). Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival. Transplant Infectious Disease. https://doi.org/10.1111/tid.14371
Vancouver
Breyer I, Ptak L, Stoy D, Mandelbrot D, Parajuli S. Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival. Transplant Infectious Disease. 2024. doi:10.1111/tid.14371
BibTeX
@article{Breyer2024,
author = {Breyer, Isabel and Ptak, Lucy and Stoy, David and Mandelbrot, Didier and Parajuli, Sandesh},
title = {Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14371}
}
EUVIMED